Kenneth Siddle

Title: Kenneth Siddle: Innovator in Immunoassay Technology

Introduction

Kenneth Siddle is a notable inventor based in Lode, GB. He has made significant contributions to the field of immunoassay technology, particularly through his innovative methods for detecting antigens in liquid samples. His work has implications for various medical and diagnostic applications.

Latest Patents

Kenneth Siddle holds 1 patent for his invention titled "Immunoassay of Antigens." This patent describes a method for immunoassaying an antigen in a liquid sample. The process involves forming a complex between the antigen and two or more antibody reagents. This complex is then bound to a solid support through non-covalent bonding. The amount of complex that binds to the support is determined using various labeling methods, including radioactive, fluorimetric, and enzyme labeling. The method is particularly useful for assaying substances such as TSH, CEA, HCG, alpha-fetoprotein, immunoglobulins, viruses, allergens, bacteria, toxins, drugs, and vitamins. The use of monoclonal antibody reagents enhances the specificity of the assay and reduces non-specific binding.

Career Highlights

Kenneth Siddle is associated with Serono Diagnostics Ltd., where he has applied his expertise in immunoassay technology. His work has contributed to advancements in diagnostic methods that are crucial for medical research and patient care.

Collaborations

Some of Kenneth Siddle's notable coworkers include Gordon C Forrest and Philip R Salacinski. Their collaborative efforts have likely played a role in the development and refinement of immunoassay techniques.

Conclusion

Kenneth Siddle's contributions to immunoassay technology exemplify the impact of innovative thinking in the field of diagnostics. His patent and work at Serono Diagnostics Ltd. highlight the importance of advancements in medical technology for improving health outcomes.